Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5384-5392
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5384
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5384
Figure 1 Survival analysis in the sorafenib group and control group.
A: Disease-free survival; B: Cumulative survival. DFS: Disease-free survival; OS: Overall survival.
- Citation: Xia F, Wu LL, Lau WY, Huan HB, Wen XD, Ma KS, Li XW, Bie P. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients. World J Gastroenterol 2016; 22(23): 5384-5392
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5384.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5384